Serotonin derivatives as inhibitors of β-secretase (BACE 1)

Pharmazie

Volumn 66, Issue 4, 2011, Pages 301-305

  Takahashi, T ^a   Miyazawa, Mitsuo ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SECRETASE INHIBITOR; N 3,4 DIMETHOXY CINNAMOYL SEROTONIN; N 4 COUMAROYL SEROTONIN; N 4 METHOXY CINNAMOYL SEROTONIN; N CAFFEOYL SEROTONIN; N CINNAMOYL SEROTONIN; N FERULOYL SEROTONIN; N ISOFERULOYL SEROTONIN; N SINAPOYL SEROTONIN; SEROTONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONJUGATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; IC 50; STRUCTURE ACTIVITY RELATION;

ALGORITHMS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIOXIDANTS; ASPARTIC ACID ENDOPEPTIDASES; BIPHENYL COMPOUNDS; CHROMATOGRAPHY, THIN LAYER; CINNAMATES; HUMANS; INDICATORS AND REAGENTS; PICRATES; SEROTONIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79957633327     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0789     Document Type: Article

References (20)

1. Prasad KN, Hovland AP, Cole WC, Prasad KC, Nahreini P, Prasad EJ, Andreatta CP (2000) Multiple antioxidant in the prevention and treatment of Alzheimer disease: analysis of biologic rationale. Clin Neuropharmacol 23: 2-13. (Pubitemid 30090405)
2. Prasad KN, Cole WC, Prasad KC (2002) Risk factors for Alzheimer's disease: Role of multiole antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment. J Amer Coll Nutr 21: 506-522. (Pubitemid 36026262)
3. Dorrel S (2000) Untangling Alzheimer's disease with beta-secretase inhibitors. Drug Discov Today 5: 316-331.
4. Stachel SJ, Coburn CA, Steele TG, Jones KG, Loutzenhiser EF, Gregro AR, Rajapakse HA, Lai MT, Crouthamel MC, Xu M, Tugusgeva K, Lineberger JE, Pietrak BL, Espeseth AS, Shi XP, Chen-Dodson E, Holloway MK, Munshi S, Simon AJ, Kuo L, Vacca JP (2004) Structure-based design of potent and selective cellpermeable inhibitors of human β-secretase (BACE-1). J Med Chem Lett 47: 6447-6450. (Pubitemid 39657304)
5. Parr AJ, Bolwell BP (2000) Phenols in the plant and in man. The potential for possible nutritional enhancement of the diet by modifying the phenols content or profile. J Sci Food Agri 80: 985-1012. (Pubitemid 30319394)
6. Jeon SY, Bae KH, Seong YH, Song KS (2003) Green tea catechins as a BACE 1 (beta-secretase) inhibitor. Bioorg Med Chem Lett 13: 3905-3908.
7. Choi SH, Hur JM, Yang EJ, Jun M, Park HJ, Lee KB, Moon E, Song KS (2008) β-Secretase (BACE1) inhibitors from Perilla frutescens var. acuta. Arch Pharm Res 31: 183-187.
8. Marumoto S, Miyazawa M (2010) β-Secretase inhibitory effects of furanocoumarins from the root of Angelica dahurica. Phytother Res 24: 510-513.
9. Sakamura S, Terayama Y, Kawakatsu S, Ichihara A, Saito H (1978) Conjugated serotonins related to cathartic activity in safflower (Carthamus tinctorius L.) seeds. Agric Biol Chem 42: 1805-1806.
10. Sato H, Kawagishi H, Nishimura T, Yoneyama S, Yoshimoto Y, Sakamura S (1985) Serotobenine, a novel phenolic amide from safflower (Carthamus tinctorius L.) seeds. Agric Biol Chem 49: 2969-2974.
11. Zhang HL, Nagatsu A, Watanabe T, Sakakibara J, Okuyama H (1997) Antioxidative compounds isolated from safflower (Carthamus tinctorius L.) oil cake. Chem Pharm Bull 45: 1910-1914.
12. Roh JS, Han JY, Kim JH, Hwong JK (2004) Inhibitory effects of active compounds isolated from safflower (Carthamus tinctorius L.) seeds for melanogenesis. Biol Pharm Bull 27: 1976-1978.
13. Nagatsu A, Zhang H L, Mizukami H, Okuyama H, Sakakibara J, Tokuda H, Nishino H (2000) Tyrosinase inhibitory and anti-tumor promoting activities of compunds isolated from safflower (Carthamus tinctorius L.) and cotton (Gossypium hirsutum L.) oil cakes. Nat Prod Lett 14: 153-158.
14. Takii T, Hayashi M, Hiroma H, Chiba T, Kawashima S, Zhang H L, Nagatsu A, Sakakibara J, Onozaki K (1999). Serotonin derivative, N-(p-coumaroyl) serotonin, isolated from safflower (Carthamus tinctorius L.) oil cake augments the proliferation of normal human and mouse fibroblasts in synergy with basic fibroblasts growth factor (bFGF) or epidermal growth factor (EGF). J Biochem 125: 910-915. (Pubitemid 29253560)
15. Park JB (2008) Serotomide and safflomide modulate forskolin-stimulated cAMP formation via 5-HT1 receptor. Phytomedicine 15: 1093-1098.
16. Yamazaki Y, Kawano Y, Yamanaka A, Maruyama S (2009) N-[(Dihydroxyphennyl) acyl]serotonins as potent inhibitors of tyrosinase from mouse and human malanoma cells. Bioorg Med Chem Lett 19: 4178-4182.
17. Kang K, Park S, Kim Y S, Lee S, Back K (2009) Biosynthesis and biotechnological production of serotonin derivatives. Appl Microbiol Biotechnol 83: 27-34.
18. Koyama N, Kuribayashi K, Seki T and Kobayashi K Furuhata Y, Suzuki K, Arisaka H, Nakano T, Amino Y and Ishii K (2006) Serotonin derivatives, major safflower (Carthamus tinctorius L.) seed antioxidants, inhibit low-density lipoprotein (LDL) oxidation and atherosclerosis in apolipoprotein E-deficient Mice. J Agric Food Chem 54: 4970-4976. (Pubitemid 44140890)
19. Somei M, Yamada F, Kurauchi T, Nagahama Y, Hasegawa M, Yamada K, Teranishi S, Sato H, Kaneko C (2001) The chemistry of indole.CIII. Simple syntheses of serotonin, N-methylserotonin, bufotenine, 5-methoxy-N- methyltryptamine, bufobutanoic acid, N-(indole-3-yl) methy-5- methoxy-N-methyltryptamine, and lespedamine based on1-hydroxyindole chemistry. Chem Pharm Bull 49: 87-96.
20. Gaspar A, Garrido E M, Esterves M, Quezada E, Milhazes N, Garrido J, Borges F (2009) New insights into the antioxidant activity of hydroxycinnamic acids: Synthesis and physicochemical characterization of novel hagenated derivatives. Eur J Med Chem 44: 2092-2099.